WecLac® Individual Clinical Strains
Clinically Studied
SCI/Patent Supported
SCI/Patent Supported
Bifidobacterium breveBBr60
Study Design
800B CFU/g
Source of Strain
Healthy infant intestines
Deposit Number
PTA-126819 (ATCC) DSM 35053(DSMZ)
Functions
-
Gastrointestinal Health -
Emotional Health -
Metabolic Health -
Maternal & Child Health -
Immune Health -
Oral Health
Specialization Advantages
40,000+ Strain Resources
GRAS certified
Allergen free
SCI / Patent supported
High survivability
Non-GMO verified
Clinically studied
High colonisation rate
Precise function
Industrialization Advantages
High potency
Low water activity
Cost-effectiveness
High stability
Fast delivery
cGMP standard
Excellent batch stability
Stable supply chain
Advanced equipment
Application
-
Dietary Supplement -
Food -
Dairy -
Precision Medicine -
Personal Care -
Feed Additive/Pet
WecLac® Individual Clinical Strains
Akkermansia muciniphila Akk11
Lactobacillus acidophilus LA85
Bifidobacterium longum subsp. longum BL21
Lacticaseibacillus rhamnosus LRa05
Lacticaseibacillus paracasei LC86
Bifidobacterium animalis subsp. lactis BLa80
Lactiplantibacillus plantarum Lp05
Pediococcus acidilactici PA53
Weizmannia coagulans BC99
No.999,Guangming Rd., Wujiang Economic and Technological Development Zone, Suzhoum City, Jiangsu Province, China
Leave a Message
Email
Linkedin